nodes	percent_of_prediction	percent_of_DWPC	metapath
Equilin—SHBG—Medroxyprogesterone Acetate—uterine cancer	0.469	0.602	CbGbCtD
Equilin—SHBG—Progesterone—uterine cancer	0.311	0.399	CbGbCtD
Equilin—HSD17B1—Steroid Biosynthesis—HSD17B2—uterine cancer	0.0705	0.411	CbGpPWpGaD
Equilin—HSD17B1—Estrogen biosynthesis—CYP19A1—uterine cancer	0.0354	0.206	CbGpPWpGaD
Equilin—SHBG—semen—uterine cancer	0.013	0.307	CbGeAlD
Equilin—HSD17B1—Metabolism of steroid hormones and vitamin D—SRD5A2—uterine cancer	0.0118	0.0689	CbGpPWpGaD
Equilin—HSD17B1—female reproductive system—uterine cancer	0.0105	0.25	CbGeAlD
Equilin—HSD17B1—female gonad—uterine cancer	0.0096	0.227	CbGeAlD
Equilin—HSD17B1—Metabolism of steroid hormones and vitamin D—AKR1B1—uterine cancer	0.00854	0.0498	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of steroid hormones and vitamin D—STAR—uterine cancer	0.00854	0.0498	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of steroid hormones and vitamin D—CYP11A1—uterine cancer	0.00511	0.0298	CbGpPWpGaD
Equilin—HSD17B1—Diseases associated with visual transduction—AKR1B10—uterine cancer	0.00394	0.023	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of steroid hormones and vitamin D—CYP19A1—uterine cancer	0.00376	0.0219	CbGpPWpGaD
Equilin—HSD17B1—Diseases associated with visual transduction—AKR1C1—uterine cancer	0.00269	0.0157	CbGpPWpGaD
Equilin—SHBG—endometrium—uterine cancer	0.00215	0.0508	CbGeAlD
Equilin—HSD17B1—Diseases associated with visual transduction—AKR1C3—uterine cancer	0.00207	0.0121	CbGpPWpGaD
Equilin—SHBG—uterus—uterine cancer	0.00198	0.0468	CbGeAlD
Equilin—SHBG—female reproductive system—uterine cancer	0.00178	0.0421	CbGeAlD
Equilin—SHBG—female gonad—uterine cancer	0.00162	0.0383	CbGeAlD
Equilin—SHBG—vagina—uterine cancer	0.00161	0.038	CbGeAlD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.00121	0.00706	CbGpPWpGaD
Equilin—Estriol—ESR2—uterine cancer	0.00116	0.171	CrCbGaD
Equilin—Estropipate—ESR2—uterine cancer	0.000891	0.131	CrCbGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.000875	0.0051	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.000875	0.0051	CbGpPWpGaD
Equilin—SHBG—Nongenotropic Androgen signaling—PIK3CA—uterine cancer	0.000847	0.00494	CbGpPWpGaD
Equilin—SHBG—Nongenotropic Androgen signaling—HRAS—uterine cancer	0.000784	0.00457	CbGpPWpGaD
Equilin—Estriol—ESR1—uterine cancer	0.000717	0.105	CrCbGaD
Equilin—SHBG—Nongenotropic Androgen signaling—AKT1—uterine cancer	0.000692	0.00403	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.000643	0.00375	CbGpPWpGaD
Equilin—Ethinyl Estradiol—ESR2—uterine cancer	0.000636	0.0933	CrCbGaD
Equilin—Conjugated Estrogens—ESR2—uterine cancer	0.000556	0.0815	CrCbGaD
Equilin—Estrone—ESR2—uterine cancer	0.000554	0.0813	CrCbGaD
Equilin—Estropipate—ESR1—uterine cancer	0.000549	0.0804	CrCbGaD
Equilin—HSD17B1—Metabolism—NDUFB11—uterine cancer	0.000539	0.00314	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—SRD5A2—uterine cancer	0.000539	0.00314	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	0.000524	0.00305	CbGpPWpGaD
Equilin—HSD17B1—Disease—AKR1B10—uterine cancer	0.000501	0.00292	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	0.000495	0.00288	CbGpPWpGaD
Equilin—Estradiol—ESR2—uterine cancer	0.00042	0.0616	CrCbGaD
Equilin—HSD17B1—Disease—RNF43—uterine cancer	0.000415	0.00242	CbGpPWpGaD
Equilin—Ethinyl Estradiol—ESR1—uterine cancer	0.000392	0.0575	CrCbGaD
Equilin—HSD17B1—Metabolism—AKR1B1—uterine cancer	0.00039	0.00227	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—STAR—uterine cancer	0.00039	0.00227	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	0.000385	0.00225	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—AKR1B10—uterine cancer	0.000351	0.00204	CbGpPWpGaD
Equilin—Conjugated Estrogens—ESR1—uterine cancer	0.000342	0.0502	CrCbGaD
Equilin—HSD17B1—Disease—AKR1C1—uterine cancer	0.000342	0.00199	CbGpPWpGaD
Equilin—Estrone—ESR1—uterine cancer	0.000341	0.0501	CrCbGaD
Equilin—HSD17B1—Metabolism—POLD1—uterine cancer	0.000306	0.00178	CbGpPWpGaD
Equilin—HSD17B1—Disease—DCN—uterine cancer	0.000296	0.00172	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—RNF43—uterine cancer	0.000291	0.00169	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—AKR1C1—uterine cancer	0.000286	0.00167	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—INHBA—uterine cancer	0.000266	0.00155	CbGpPWpGaD
Equilin—HSD17B1—Disease—AKR1C3—uterine cancer	0.000263	0.00153	CbGpPWpGaD
Equilin—Estradiol—ESR1—uterine cancer	0.000259	0.0379	CrCbGaD
Equilin—HSD17B1—Disease—HMGA1—uterine cancer	0.000256	0.00149	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—RRM2—uterine cancer	0.000255	0.00149	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—DCN—uterine cancer	0.000248	0.00144	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—AKR1C1—uterine cancer	0.000239	0.00139	CbGpPWpGaD
Equilin—HSD17B1—Disease—FBXW7—uterine cancer	0.000234	0.00137	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CYP11A1—uterine cancer	0.000233	0.00136	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—AKR1C3—uterine cancer	0.00022	0.00128	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—AKR1C3—uterine cancer	0.000184	0.00107	CbGpPWpGaD
Equilin—HSD17B1—Disease—CDKN2B—uterine cancer	0.000184	0.00107	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PGR—uterine cancer	0.00018	0.00105	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CYP19A1—uterine cancer	0.000172	0.001	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—STK11—uterine cancer	0.000172	0.001	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—YWHAE—uterine cancer	0.000171	0.000998	CbGpPWpGaD
Equilin—HSD17B1—Disease—SMAD3—uterine cancer	0.000168	0.000978	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—FBXW7—uterine cancer	0.000164	0.000957	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	0.000161	0.000939	CbGpPWpGaD
Equilin—HSD17B1—Disease—FGFR2—uterine cancer	0.00016	0.000933	CbGpPWpGaD
Equilin—HSD17B1—Disease—MTHFR—uterine cancer	0.000154	0.000898	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	0.000154	0.000896	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—STK11—uterine cancer	0.000144	0.000837	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—SOCS3—uterine cancer	0.000134	0.000783	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—MTHFR—uterine cancer	0.000129	0.000752	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CDKN2B—uterine cancer	0.000129	0.00075	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IGF1R—uterine cancer	0.000125	0.000728	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—SMAD3—uterine cancer	0.000117	0.000685	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	0.000114	0.000663	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—FGFR2—uterine cancer	0.000112	0.000653	CbGpPWpGaD
Equilin—HSD17B1—Disease—ERBB2—uterine cancer	0.0001	0.000586	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ESR1—uterine cancer	9.58e-05	0.000559	CbGpPWpGaD
Equilin—HSD17B1—Disease—CDKN1B—uterine cancer	9.3e-05	0.000542	CbGpPWpGaD
Equilin—HSD17B1—Disease—CTNNB1—uterine cancer	8.79e-05	0.000512	CbGpPWpGaD
Equilin—HSD17B1—Disease—PTEN—uterine cancer	8.57e-05	0.000499	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CCL2—uterine cancer	8.44e-05	0.000492	CbGpPWpGaD
Equilin—HSD17B1—Disease—EP300—uterine cancer	8.17e-05	0.000476	CbGpPWpGaD
Equilin—HSD17B1—Disease—NRAS—uterine cancer	7.64e-05	0.000446	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PTEN—uterine cancer	7.17e-05	0.000418	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ERBB2—uterine cancer	7.04e-05	0.00041	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—EP300—uterine cancer	6.84e-05	0.000399	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CXCL8—uterine cancer	6.67e-05	0.000389	CbGpPWpGaD
Equilin—HSD17B1—Disease—KRAS—uterine cancer	6.58e-05	0.000384	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CDKN1B—uterine cancer	6.52e-05	0.00038	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CTNNB1—uterine cancer	6.16e-05	0.000359	CbGpPWpGaD
Equilin—HSD17B1—Disease—PIK3CA—uterine cancer	6.04e-05	0.000352	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PTEN—uterine cancer	6e-05	0.00035	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—EP300—uterine cancer	5.72e-05	0.000334	CbGpPWpGaD
Equilin—HSD17B1—Disease—HRAS—uterine cancer	5.59e-05	0.000326	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—VEGFA—uterine cancer	5.42e-05	0.000316	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NRAS—uterine cancer	5.35e-05	0.000312	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PIK3CA—uterine cancer	5.06e-05	0.000295	CbGpPWpGaD
Equilin—HSD17B1—Disease—AKT1—uterine cancer	4.94e-05	0.000288	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—KRAS—uterine cancer	4.61e-05	0.000269	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PIK3CA—uterine cancer	4.23e-05	0.000247	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—AKT1—uterine cancer	4.13e-05	0.000241	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—TP53—uterine cancer	4.09e-05	0.000239	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—HRAS—uterine cancer	3.92e-05	0.000228	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—AKT1—uterine cancer	3.46e-05	0.000202	CbGpPWpGaD
